UNIONDALE, NY / ACCESS Newswire / December 5, 2025 / Marquis Who's Who, the trusted biographical authority documenting accomplished professionals since 1899, is proud to announce that Mona Dickson ...

Capricor Therapeutics faces high regulatory risks for its DMD therapy. Get expert analysis on trial data and FDA challenges.

Objective Systemic corticosteroids for 5–7 days are standard care for asthma exacerbations, but the optimal duration and ...

This valuable study presents an analysis of the gene regulatory networks that contribute to tumour heterogeneity and tumor plasticity in Ewing sarcoma, with key implications for other fusion-driven ...

This month's LCGC Blog from Jonnie Shackman from the America Chemical Society (ACS) reflects on how early experiences with computer programming shaped the author’s understanding of fundamental logic, ...

In many rodent laboratories, blood samples are collected from rats using the tail vein nick procedure and analyzed to quantify blood corticosterone levels as an indicator of stress. The standard ...

Green Transformational Leadership on Green Creativity: A Quantitative Study Within the Ghanaian Manufacturing Industry ...

Time-to-event is a powerful statistical approach increasingly used in sports science and medicine to examine time-to-event outcomes such as time to sports injury occurrence, career duration and ...

Agarwala, S. and Vijayvargiya, M. (2025) Additional Dose of Zolendronic Acid for Inadequate Response in Avascular Necrosis.

Objective The question of sustained remission in SLE has been highlighted recently following data published on the use of chimeric antigen receptor-T cell therapy in SLE. With the review, we wanted to ...

Many questions remain about UNC-Chapel Hill’s plan to merge the schools of Data Science and Society and Information and Library Science.

Objective To assess the feasibility of conducting a cluster randomised controlled trial comparing the effects of Advanced Trauma Life Support (ATLS) and Primary Trauma Care (PTC) with standard care on ...